Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_assertion type Assertion NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_head.
- NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_provenance.
- NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_assertion evidence source_evidence_literature NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_provenance.
- NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_assertion SIO_000772 24014145 NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_provenance.
- NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_assertion wasDerivedFrom befree-2016 NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_provenance.
- NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_assertion wasGeneratedBy ECO_0000203 NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_provenance.